Close
13/12/2017
ALBA Synchrotron Works for People’s Health
Two recent works remind us that ALBA synchrotron is a very valuable tool to help develop new drugs.

On one hand, using the MIRAS beam line of the ALBA synchrotron (infrared radiations), researchers from the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron have demonstrated in a paper the capability of metalosomes - aggregates made of phospholipids and metal complexes - to interact with cells and release carbon monoxide in a controlled way (CO release can be beneficial because of its anti-inflammatory, vasodilator and cardio protective properties).
 
On the other hand, in another publication, a team led by researchers from the Universitat Politècnica de Catalunya (UPC) has unveiled the mechanism of action of two drugs, FR60 and JNI18, which cure 100% of mice with sleeping sickness. Using X-rays of the ALBA XALOC beam line, they have observed how these drugs perfectly stacked on the Trypanosoma brucei’s DNA, the parasite that causes the disease (image). Blocking and inflicting specific damage on its DNA, the parasite cannot reproduce and finally dies after 4-5 days.
 

More news

19/12/2016 ​Foundation stone ceremony for Natura Bissé’s new world headquarters in Barcelona Synchrotron Park 15/12/2016 ​The Bioregion of Catalonia in Nature 07/12/2016 Digitus II Awarded By Barcelona Synchrotron Park As Best Business Idea Of The UAB University Research Park 29/11/2016 ​The European Commission awards the “Business & Biodiversity” label to Barcelona Synchrotron Park 21/11/2016 ​Barcelona 2nd Smart City in the World 15/11/2016 Barcelona Synchrotron Park Sponsors the PRUAB Ideas Generation Program
20 21 22 23 24 25 26 27 28 29 30